Education

The Satellite Meetings listed below are not part of the official ASAM Annual Conference as planned by its Program Committee.  Attendance is optional, and in some cases, there is limited seating. 

There will be six satellite meetings adjunct to the ASAM Annual Conference. Please take a look at the events listed below.


Changing the Narrative of Opioid & Alcohol Dependence Treatment

SPONSORED BY: ALKERMES

Friday, April 13, 2017
7:00 pm – 8:30 pm
Hilton San Diego Bayfront
Indigo 204, Level 2

Stacy Cohen, MD
Mental Health Center at Cedars Sinai
Associate Medical Director for Substance Use Disorders
Pacific Clinics
Los Angeles, CA

This evening presentation focuses on the way we look at the treatment of opioid and alcohol dependence.  Dr. Cohen will discuss how opioids and alcohol affect the brain potentially leading to dependence and an in-depth review of one medication-assisted treatment (MAT) option. 

No CME credits are available for this presentation.

UNB-001578


Join Carlos Tirado, MD, MPH, for a presentation about new SUBLOCADE
A Once-monthly Buprenorphine Injection for the Treatment of Moderate to Severe Opioid Use Disorder

SPONSORED BY: INDIVIOR

Friday, April 13, 2018
7:00 pm – 8:30 pm
Hilton San Diego Bayfront
Indigo Ballroom DH, Level 2

Dinner will be served.

Medication Assisted Treatment for Opioid Use Disorder: Spotlight on Probuphine ® (buprenorphine)

SPONSORED BY: BRAEBURN PHARMACEUTICALS

Saturday, April 14, 2018
6:30 pm – 8:00 pm
Hilton San Diego Bayfront
Sapphire IM, Level 4

Opioid Use Disorder (OUD) is one of the most serious and urgent problems facing our society, with broad-reaching consequences. Despite compelling evidence that Medication Assisted Treatment (MAT) is a proven comprehensive approach, barriers still exist, and MAT is currently underused. This program will gather a panel of experts to discuss the impact of this crisis, strategies for overcoming barriers to MAT, review the clinical experience of experts who utilize Probuphine and hear first-hand the impact this therapy has had on patients.


Join Carlos Tirado, MD, MPH, for a presentation about new SUBLOCADE
A Once-monthly Buprenorphine Injection for the Treatment of Moderate to Severe Opioid Use Disorder

SPONSORED BY: INDIVIOR

Saturday, April 14, 2018
6:30 pm – 8:00 pm
Hilton San Diego Bayfront
Indigo Ballroom DH, Level 2

Dinner will be served


Naloxone—If Not Now, When? Demystifying the Conversation

SPONSORED BY: KALEO

Saturday, April 14, 2018
6:30 PM: Registration and Dinner
7:00 PM – 8:00 PM: Symposium 
Hilton San Diego Bayfront
Sapphire Ballroom AE, Level 4

Patients with opioid use disorder are at risk for opioid overdose throughout the continuum of care. Opioid overdose deaths continue to increase year after year, despite take-home naloxone being available for providers to coprescribe for patients in order to help reverse an opioid overdose. Timely naloxone administration is important because without intervention, hypoxia resulting from opioid overdose may lead to permanent brain damage in as little as 4 minutes. However, the average emergency medical services response time is approximately 13 minutes. 

During this symposium, the faculty will provide guidance on how to identify patients at risk and initiate the conversation with them about opioid overdose and the need for take-home naloxone as part of their treatment plan. In addition, the faculty will offer their best practices when coprescribing naloxone, educating patients and care partners, and creating an opioid emergency plan.

LEARNING OBJECTIVES
After attending this symposium, participants should be better able to:

• Describe the need to coprescribe take-home naloxone to help reverse an opioid overdose.
• Initiate the conversation with at-risk patients and care partners around opioid overdose and the need for take-home naloxone. 
• Implement a strategy to create an opioid emergency plan that includes education and coprescribing take-home naloxone for at-risk patients and care partners.

Register now: www.surveymonkey.com/r/kaleoASAM2018

FACULTY
Antonio F. De Filippo, MD  
Chief Executive Officer,
South Florida Psychiatric Services, Pembroke Pines, Florida

Stacy E. Seikel, MD
Chief Medical Officer,
Integrated Recovery Programs,
RiverMend Health Center of Atlanta, Atlanta, Georgia

Joanna G. Katzman, MD, MSPH
Professor, Department of Neurosurgery
Secondary Appointments,
Departments of Psychiatry and College of Nursing
Director, UNM Pain Center and Project 
ECHO Pain (Indian Health Service and 
Defense Health Agency Programs)
University of New Mexico Health Sciences Center,
Albuquerque, New Mexico

Dinner will be Served.


Accredited CE/CME Symposium: Combating Opioid Dependence Amidst an Epidemic

SUPPORTED BY: AN EDUCATIONAL GRANT FROM INDIVIOR 

Sunday, April 15, 2018
12:00-1:30 pm
Hilton San Diego Bayfront
Aqua 300, Level 3

In the United States, opioid dependence has reached epidemic proportions. In the United States, on average, 115 Americans die every day from opioid overdoses. Additionally, opioid dependence affects an estimated 5 million individuals and results in an estimated 17,000 deaths annually. Due to the ongoing epidemic, ER visits continue to increase, and billions of dollars are spent on medical care for those with opioid dependence. Results from a study published in April 2017 revealed that more than one-fifth of those with opioid dependence in a large health system died during a four-year follow-up period.

Please join Pharmacy Times Continuing Education (PTCE) and Physician’s Education Resource (PER) for a live symposium which will discuss current and emerging treatment and drug delivery options for opioid dependence through comparing efficacy, safety, and adherence data. Furthermore, the faculty will address proper agent selection based on an individual’s characteristics and health history, and identify populations who may benefit from a long acting injectable. Lastly, the discussion will encourage a multidisciplinary, systematic approach to treating opioid dependence through all stages of care including diagnosis, agent selection, and treatment monitoring.  

Registration Link: Soon to come! Please visit pharmacytimes.org

This activity is supported by an educational grant from Indivior.